This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Greg Thurber, PhD
Professor, Chemical Engineering and Biomedical Engineering at University of Michigan
Speaker

Profile

Greg Thurber is Professor of Chemical Engineering and Biomedical Engineering at the University of Michigan where his work focuses on applying fundamental biotransport principles to design novel therapeutics and molecular imaging agents. He received his PhD training at MIT and postdoctoral training at Mass General Hospital and Harvard Medical School. Prof. Thurber has authored over 80 papers and book chapters and delivered 130 invited talks at major pharmaceutical companies, national and international conferences, and university seminars. He has consulted/collaborated with more than 20 different companies including on several projects for ADCs that have since been FDA approved.

Agenda Sessions

  • Dissecting the Interplay between ADC Treatment and the Tumor Microenvironment

    14:05